Mometasone Furoate Cutaneous Emulsion is a topical medication used in this trial to treat plaque psoriasis. It is applied directly to the skin and works by reducing inflammation, redness, and itching associated with psoriasis. The goal of the trial is to determine if this emulsion is as effective as other treatments in managing the symptoms of psoriasis.

Ecural® Fat Cream is another topical treatment used in the trial for plaque psoriasis. It is applied to the skin to help reduce the symptoms of psoriasis, such as redness, thickening, and scaling. The trial compares this cream to the mometasone furoate emulsion to evaluate their effectiveness in treating psoriasis.

Plaque Psoriasis – Plaque psoriasis is a chronic autoimmune condition that primarily affects the skin, leading to the development of raised, red patches covered with a silvery white buildup of dead skin cells. These patches, known as plaques, can appear anywhere on the body but are most commonly found on the elbows, knees, scalp, and lower back. The condition is characterized by cycles of flare-ups and remission, where symptoms may improve or worsen over time. The skin lesions are often itchy and can be painful, sometimes cracking and bleeding. The exact cause of plaque psoriasis is not fully understood, but it involves an overactive immune response that accelerates the growth cycle of skin cells. Environmental factors, stress, and certain medications can trigger or exacerbate the symptoms.